Select for export The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case Study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2147/imcrj.s395342 PubMed 36896410 Copy citation Copy BibTeX International Medical Case Reports Journal 2023-02-28 Daniel A Kinderlehrer OpenAlex Published psilocybin Receptor PharmacologyMicrodosingReview Article Review Article More
Select for export Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put First Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2023.03.3.43 Copy citation Copy BibTeX Psychiatric News 2023-02-15 Jacques Ambrose, J.S. Zabinski OpenAlex Published psilocybin DepressionPTSDPharmacology Clinical Trial More
Select for export Psychedelics Legislation Gains Momentum Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2023.03.3.4 Copy citation Copy BibTeX Psychiatric News 2023-02-15 Terri D’Arrigo OpenAlex Published psilocybin Mechanism of ActionReceptor PharmacologySafety Other More
Select for export The History, Legalization and Potentials of Psilocybin-Assisted Psychotherapy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31275/20222633 Copy citation Copy BibTeX Journal of Scientific Exploration 2023-02-10 Jeffery Heilman OpenAlex Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Therapeutic effect of psilocybin in addiction: A systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1134454 PubMed 36846225 Copy citation Copy BibTeX Unknown journal 2023-02-08 van der Meer PB, Fuentes JJ, Kaptein AA, Schoones JW, de Waal MM, Goudriaan AE Europe PMC Published psilocybin AddictionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export Hofmann vs. Paracelsus: Do Psychedelics Defy the Basics of Toxicology?-A Systematic Review of the Main Ergolamines, Simple Tryptamines, and Phenylethylamines. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/toxics11020148 PubMed 36851023 Copy citation Copy BibTeX Unknown journal 2023-02-02 Henríquez-Hernández LA, Rojas-Hernández J, Quintana-Hernández DJ, Borkel LF. Europe PMC Published psilocybin Mechanism of ActionSystematic ReviewReview Article Systematic Review More
Select for export Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jad.2023.01.108 PubMed 36740140 Copy citation Copy BibTeX Journal of Affective Disorders 2023-02-02 Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Merve Atli, James Bennett, Megan Croal OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export Plant Medicine Healing! Discovering the Roots of Psychedelic-Assisted Therapy in Mental Health Abstract available at the source but not redistributed here. Read at source. Details DOI 10.9734/air/2023/v24i1931 Copy citation Copy BibTeX Advances in Research 2023-01-29 Jennings Hernandez OpenAlex Published psilocybin DepressionAnxietyPTSD Observational Study More
Select for export SV2A Marker of Synaptogenesis in a Clinical Trial of Psilocybin for Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2023-01-29 Washington University School of Medicine ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionNeuroplasticityBrain Imaging Clinical Trial More
Select for export Psychedelics: Science sabotaged by Social Media. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2023.109426 PubMed 36693562 Copy citation Copy BibTeX Unknown journal 2023-01-20 Sellers EM, Romach MK. Europe PMC Published psilocybin Safety Other More
Select for export Classic psychedelics do not affect T cell and monocyte immune responses Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1042440 PubMed 36741125 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-01-19 Deborah Rudin, Alexander Areesanan, Matthias E. Liechti, Carsten Gründemann OpenAlex Published psilocin End-of-Life DistressPharmacologyReceptor Pharmacology In Vitro Study More
Select for export Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1556/2054.2022.00222 Copy citation Copy BibTeX Journal of Psychedelic Studies 2023-01-17 Benjamin R. Lewis, Kevin Byrne, John Hendrick, Eric L. Garland, Paul Thielking, Anna C. Beck OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
Select for export Pilot Trial of Visual Healing®, a Nature-themed Virtual Immersive Experience, to Optimize Set and Setting in Psilocybin-assisted Therapy for Alcohol Use Disorder Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2023-01-16 Keith Heinzerling ClinicalTrials.gov CLINICAL TRIAL psilocybin AnxietyAddictionMystical Experience Clinical Trial More
Select for export Psychedelics for Patients With Cancer: A Comprehensive Literature Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/10600280221144055 PubMed 36635883 Copy citation Copy BibTeX Unknown journal 2023-01-11 White CM, Weisman N, Dalo J. Europe PMC Published psilocybin DepressionAnxietyMechanism of Action Randomized Controlled Trial More
Select for export Are psychedelics the answer to chronic pain: A review of current literature. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/papr.13203 PubMed 36597700 Copy citation Copy BibTeX Unknown journal 2023-01-10 Kooijman NI, Willegers T, Reuser A, Mulleners WM, Kramers C, Vissers KCP Europe PMC Published psilocybin AddictionEnd-of-Life DistressChronic Pain Randomized Controlled Trial More
Select for export Healing at death’s door: one patient’s mystical experience with psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.26443/ijwpc.v10i1.373 Copy citation Copy BibTeX International Journal of Whole Person Care 2023-01-05 Houman Farzin OpenAlex Published psilocybin End-of-Life DistressSpiritualityMystical Experience Other More
Select for export An Integrative Review of Measures of Spirituality in Experimental Studies of Psilocybin in Serious Illness Populations. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/10499091221147700 PubMed 36604312 Copy citation Copy BibTeX Unknown journal 2023-01-04 Baker KM, Ulrich CM, Meghani SH. Europe PMC Published psilocybin WellbeingSpiritualityMystical Experience Review Article More
Select for export Change in whole blood BDNF after escitalopram or psilocybin intervention in patients with depression and healthy controls No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.103646 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 Miriam L. Navarro, Alberte Wollesen Breum, Annette Johansen, Brice Ozenne, Vibe G. Frøkjær, Gitte M. Knudsen OpenAlex Published psilocybin DepressionAnxietyPersonality Change Other More
Select for export Italian psychedelic therapies of the past century: An historical overview Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20503245231179687 Copy citation Copy BibTeX Drug Science Policy and Law 2022-12-31 Adriana D’Arienzo, Giorgio Samorini OpenAlex Published psilocybin DepressionReceptor Pharmacology Other More
Select for export Efficacy and Safety of Psychedelics in Treating Anxiety Disorders Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31486/toj.23.0076 PubMed 38143548 Copy citation Copy BibTeX Ochsner Journal 2022-12-31 Leah Feulner, Thanpicha Sermchaiwong, Nathan Rodland, David Galarneau OpenAlex Published psilocybin AnxietyAgingClinical Trial Clinical Trial More
